NCT06116513View on ClinicalTrials.gov

Secondary Obliteration of Old Radical Cavities Using S53P4 Bioactive Glass

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions

Mastoid Cavity

Interventions

DEVICE

S53P4 bioactive glass granules

During revision surgery, all infectious material would be removed and subsequently the posterior wall of the external ear canal would be reconstructed and the mastoid would be obliterated using S53P4 bioactive glass.

Trial Locations (1)

3582KE

RECRUITING

Diakonessenhuis, Utrecht

All Listed Sponsors

lead

Diakonessenhuis, Utrecht

OTHER

NCT06116513 - Secondary Obliteration of Old Radical Cavities Using S53P4 Bioactive Glass | Biotech Hunter | Biotech Hunter